LXRX Stock Soars 75% This Week: Terminates Agreement with Sanofi

LXRX stock

LXRX stock is making a big move this week, with a gain of over 75% this week after Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) ended a collaboration agreement with Sanofi (NASDAQ:SNY).

Sanofi News Gives Boost

The pharmaceutical sector has been one of the most dynamic sectors for investors for many decades, and it continues to be so as many companies are making important advancements. Every week there are important developments in the sector that are picked up by investors to work on their strategies.

This week, Lexicon Pharmaceuticals has proven to be one of the biggest ...

Read The Full Article On MicroSmallCap.com

Get early insight on hidden secret gems on MicroSmallCap. Follow Crypto, Mining, Cannabis and Energy stocks and get free research reports here.

All content provided by MicroSmallCap is subject to our Terms Of Use and Disclaimer.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.